18F-FDG PET/CT in tuberculosis: An early non-invasive marker of therapeutic response

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 9, 2012, Pages 1180-1185

  Martinez, Valérie ^a   Castilla Lievre, M A ^b   Guillet Caruba, C ^b   Grenier, G ^a   Fior, R ^a   Desarnaud, S ^c   Doucet Populaire, F ^b   Boue F ^a  

^a INSERM   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

18F FDG PET CT; Extrapulmonary; SUVmax; Therapy; Tuberculosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; LIVER BIOPSY; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPUTUM SMEAR; SYNDROME DELINEATION; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; FEMALE; FLUORODEOXYGLUCOSE F18; FRANCE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84865253597     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0010     Document Type: Article

References (26)

1. World Health Organization. Global tuberculosis control report 2010. Geneva, Switzerland: WHO, 2010. http://www.who.int/tb/publications/global- report/en/ Accessed May 2012.
2. te Beek L A, van der Werf M J, Richter C, Borgdorff M W. Extrapulmonary tuberculosis by nationality, The Netherlands, 1993-2001. Emerg Infect Dis 2006; 12: 1375-1382. (Pubitemid 44455213)
3. Figoni J, Antoine D, Che D. Les cas de tuberculose déclarés en France en 2009. Bull Epidémiol Hebd 2011; 22: 258-260.
4. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18- fluorodeoxyglucose uptake. J Nucl Med 1994; 35: 104-112. (Pubitemid 24018451)
5. Bakheet S M, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998; 23: 739-742. (Pubitemid 28496224)
6. Demura Y, Tsuchida T, Uesaka D, et al. Usefulness of 18F- fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis. Eur J Nucl Med Mol Imaging 2009; 36: 632-639.
7. Goo J M, Im J G, Do K H, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000; 216: 117-121. (Pubitemid 30434730)
8. Harisankar C, Mittal B R, Bhattacharya A, Singh B. FDG-PET/CT in diagnosis and early response evaluation of extra-pulmonary tuberculosis in a patient with aplastic anemia. J Postgrad Med 2010; 56: 219-221.
9. Hofmeyr A, Lau W F, Slavin M A. Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response. Tuberculosis (Edinb) 2007; 87: 459-463. (Pubitemid 47314357)
10. Kim I J, Lee J S, Kim S J, et al. Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity. Eur J Nucl Med Mol Imaging 2008; 35: 808-814.
11. Kumar A, Dutta R, Kannan U, Kumar R, Khilnani G C, Gupta S D. Evaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation. Ann Thorac Med 2011; 6: 11-16.
12. Park I N, Ryu J S, Shim T S. Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med 2008; 33: 1-3.
13. Tian G, Xiao Y, Chen B, Xia J, Guan H, Deng Q. FDG PET/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis. Acta Radiol 2010; 51: 1002-1006.
14. Soussan M, Brillet P Y, Mekinian A, et al. Patterns of pulmonary tuberculosis on FDG-PET/CT. Eur J Radiol 2011; Sep 24 [Epub ahead of print].
15. Steingart K R, Ng V, Henry M, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6: 664-674. (Pubitemid 44462695)
16. Steingart K R, Ramsay A, Pai M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther 2007; 5: 327-331. (Pubitemid 47050155)
17. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
18. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010; 48: 2495-2501.
19. Larson S M. Cancer or inflammation? A Holy Grail for nuclear medicine. J Nucl Med 1994; 35: 1653-1655.
20. Aragon-Ching J B, Akin E A. Positron emission tomography findings in clinical mimics of lymphoma. Ann N Y Acad Sci 2011; 1228: 19-28.
21. Bomanji J, Almuhaideb A, Zumla A. Combined PET and X-ray computed tomography imaging in pulmonary infections and inflammation. Curr Opin Pulm Med 2011; 17: 197-205.
22. Jain V, Hasselquist S, Delaney M D. PET scanning in sarcoidosis. Ann N Y Acad Sci 2011; 1228: 46-58.
23. Walzl G, Ronacher K, Hanekom W, Scriba T J, Zumla A. Immunological biomarkers of tuberculosis. Nat Rev Immunol 2011; 11: 343-354.
24. Nordin A J, Rossetti C, Rahim N A. Disseminated tuberculosis infection: a 'super' 18F-FDG PET/CT appearance. Eur J Nucl Med Mol Imaging 2009; 36: 882.
25. Meignan M, Gallamini A, Haioun C, Polliack A. Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010. Leuk Lymphoma 2010; 51: 2171-2180.
26. Wahl R L, Jacene H, Kasamon Y, Lodge M A. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50 (Suppl 1): S122-S150.